FDA approves Citius' therapy for rare blood cancer

[cafead]

via The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' (CTXR.O) therapy for patients with a form of blood cancer who have received at least one prior treatment, the company said on Thursday, an year after the regulator rejected the treatment.

article source